CEP55 and non-small cell lung carcinoma: Similarly, CEP55 was found to be up-regulated in multiple types of cancer and was related to unfavorable prognosis of non-small-cell lung cancer patients (Jiang et al., 2018) and breast cancer patients (Yin et al., 2018).